Free Trial

National Health Investors (NHI) Stock Price, News & Analysis

National Health Investors logo
$75.57 +0.64 (+0.86%)
As of 03:14 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About National Health Investors Stock (NYSE:NHI)

Advanced

Key Stats

Today's Range
$74.43
$75.73
50-Day Range
$73.17
$86.45
52-Week Range
$68.80
$91.38
Volume
598,471 shs
Average Volume
332,817 shs
Market Capitalization
$3.66 billion
P/E Ratio
24.38
Dividend Yield
4.87%
Price Target
$87.50
Consensus Rating
Moderate Buy

Company Overview

National Health Investors Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
66th Percentile Overall Score

NHI MarketRank™: 

National Health Investors scored higher than 66% of companies evaluated by MarketBeat, and ranked 448th out of 879 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    National Health Investors has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 1 strong buy rating, 4 buy ratings, 2 hold ratings, and no sell ratings.

  • Upside Potential

    National Health Investors has a consensus price target of $87.50, representing about 16.0% upside from its current price of $75.43.

  • Amount of Analyst Coverage

    National Health Investors has only been the subject of 4 research reports in the past 90 days.

  • Read more about National Health Investors' stock forecast and price target.
  • Earnings Growth

    Earnings for National Health Investors are expected to grow by 5.13% in the coming year, from $5.07 to $5.33 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of National Health Investors is 24.33, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.11.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of National Health Investors is 24.33, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 24.01.

  • Price to Earnings Growth Ratio

    National Health Investors has a PEG Ratio of 3.98. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    National Health Investors has a P/B Ratio of 2.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about National Health Investors' valuation and earnings.
  • Percentage of Shares Shorted

    4.00% of the float of National Health Investors has been sold short.
  • Short Interest Ratio / Days to Cover

    National Health Investors has a short interest ratio ("days to cover") of 3.46, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in National Health Investors has recently increased by 9.25%, indicating that investor sentiment is decreasing significantly.
  • Dividend Leadership

    National Health Investors is a leading dividend payer. It pays a dividend yield of 4.83%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    National Health Investors does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of National Health Investors is 118.71%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Dividend Sustainability

    Based on earnings estimates, National Health Investors will have a dividend payout ratio of 69.04% next year. This indicates that National Health Investors will be able to sustain or increase its dividend.

  • Read more about National Health Investors' dividend.
  • Search Interest

    Only 10 people have searched for NHI on MarketBeat in the last 30 days. This is a decrease of -17% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added National Health Investors to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, National Health Investors insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    2.70% of the stock of National Health Investors is held by insiders.

  • Percentage Held by Institutions

    62.51% of the stock of National Health Investors is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about National Health Investors' insider trading history.
Receive NHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Health Investors and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NHI Stock News Headlines

The "hidden" half of the SpaceX IPO
Most investors are focused on the SpaceX IPO - but the bigger opportunity may lie elsewhere. On Feb. 2, Elon Musk pulled off what may be the largest merger in history, combining SpaceX with his AI company, xAI. To make that combined vision a reality, Musk reportedly relies on a tiny supplier currently just 1/60th the size of SpaceX. The window to position ahead of the IPO closes June 30.tc pixel
See More Headlines

NHI Stock Analysis - Frequently Asked Questions

National Health Investors' stock was trading at $76.48 at the start of the year. Since then, NHI stock has decreased by 1.4% and is now trading at $75.43.

National Health Investors, Inc. (NYSE:NHI) released its quarterly earnings results on Monday, May, 4th. The real estate investment trust reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.21 by $0.39. National Health Investors's quarterly revenue was up 28.9% on a year-over-year basis.
Read the conference call transcript
.

National Health Investors' top institutional investors include Principal Financial Group Inc. (3.51%), Bank of America Corp DE (2.05%), Dimensional Fund Advisors LP (1.42%) and Bank of New York Mellon Corp (1.06%). Insiders that own company stock include Charlotte A Swafford and James R Jobe.
View institutional ownership trends
.

Shares of NHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that National Health Investors investors own include NVIDIA (NVDA), Meta Platforms (META), JPMorgan Chase & Co. (JPM), Intel (INTC), Tesla (TSLA), Advanced Micro Devices (AMD) and ExxonMobil (XOM).

Company Calendar

Record date for 5/1 Dividend
3/31/2026
Ex-Dividend for 5/1 Dividend
3/31/2026
Dividend Payable
5/01/2026
Last Earnings
5/04/2026
Today
5/28/2026
Next Earnings (Estimated)
8/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Finance
Industry
REIT - EQTY TRUST - OTHER
Sub-Industry
Specialized REITs
Current Symbol
NYSE:NHI
CIK
877860
Employees
20
Year Founded
1991

Price Target and Rating

High Price Target
$94.00
Low Price Target
$84.00
Potential Upside/Downside
+15.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
$3.10
Trailing P/E Ratio
24.38
Forward P/E Ratio
14.91
P/E Growth
3.98
Net Income
$142.18 million
Net Margins
36.86%
Pretax Margin
36.55%
Return on Equity
9.82%
Return on Assets
5.35%

Debt

Debt-to-Equity Ratio
0.83
Current Ratio
8.20
Quick Ratio
8.20

Sales & Book Value

Annual Sales
$375.63 million
Price / Sales
9.76
Cash Flow
$4.75 per share
Price / Cash Flow
15.90
Book Value
$31.41 per share
Price / Book
2.41

Miscellaneous

Outstanding Shares
48,470,000
Free Float
47,162,000
Market Cap
$3.66 billion
Optionable
Optionable
Beta
0.55

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NYSE:NHI) was last updated on 5/28/2026 by MarketBeat.com Staff.
From Our Partners